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AbstRAct
Leukoplakic lesion is not uncommon in clinical practice but its occurrence as a component of a syndrome is rare. Dys-
keratosis congenita is a rare genodermatosis, which is characterized by triad of skin pigmentation, nail dystrophy and 
leukoplakic lesion in the oral cavity. It is important for dentists to now about Dyskeratosis Congenita because these 
leukoplakic lesions can spontaneously undergo malignant transformation. Majority of cases have been reported in der-
matology or pediatrics literature whereas only few reports have appeared in dental literature. The purpose of reporting 
this case with review of recent literature is to create better awareness among dentists about the multisystem manifesta-
tions and oro-dental abnormalities of this fatal condition that can aid clinicians in early diagnosis.  A case of 26 year 
old male is reported with details of differential diagnosis, importance of hematological investigations, periodic biopsies 
and current concepts in management of such patients are briefly reviewed. 
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INtRODUctION
Dyskeratosis congenita (DC) is a rare, hereditary disease, 
which was first described by Zinsser in 1906(1). Later 
Engman and Cole et al reported other cases in detail 
and hence it is also known as Cole-Engman syndrome or 
Zinsser- Cole-Engman syndrome(2). DC occurs mostly in 
males and manifests between 5 to 12 years. Classic triad 
of skin pigmentation, nail dystrophy and oral leukoplakia 
occur in complete expression of this syndrome. DC is a 
fatal condition in which majority of the patients develop 
aplastic anemia and malignant transformation occur in 
the keratotic white patches(1,2) which is of considerable 
interest to a dentist.
cAsE REPORt
A man of 26 years reported for consultation regarding an 
asymptomatic white patch present on the dorsum of the 
tongue for last 4 years.  He had no habit of chewing or 
smoking tobacco. No other family member had history of 
such lesions. Patient did not report of itching, photosensi-
tivity and loss of hair.
The patient was apparently normal till the age of 5 years 
but started developing symptoms, which are summarized 
in table-1. 
Patient appeared pale but vital signs were within normal 
limits. Hyperpigmented areas were observed on the forehead 
(Fig-1), neck and trunk. Nails of both toes and fingers were 
cracked and atrophied (Fig-2). Left eye was red and patient 
reported of epiphora (Fig-1).
On intra oral examination a raised white patch of 0.5 cm in 
diameter was observed on the dorsal surface of the tongue 
(Fig-3). Lesion was not scrapable with gauze and had no 
indurated margins. The teeth, periodontium and other oral 
mucosal surfaces were normal.
Considering the symptoms of  skin pigmentation, nail 
dystrophy and white patch a differential diagnosis of pach-
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yonychia congenita and DC were considered. Hematological 
investigations, bone aspiration and biopsy of tongue lesion 
were ordered. Hematological investigations revealed reduced 
levels of hemoglobin [5.6 mmol/L (normal 8.1-11.2 mmol/
L)] and platelets [90X109/L (normal 150 – 450X109/L)] 
with white blood cells (WBC) count of 4.2X109/L (normal 
4X109/L), which is towards the lower limit. On basis of 
the hematological report a definitive diagnosis of DC was 
made. 
The patient was referred for ophthalmologic consultation. 
The Ophthalmologist reported of a growth in the left fun-
dus region with punctal atresia (Fig-1) and a biopsy was 
recommended.
However, the biopsy was not performed as the patient re-
fused to undergo the procedure.
Histopathological report of  the tongue lesion revealed 
hyperkeratosis with flattened rete ridges. Connective tissue 
showed fibro-collagenous tissue with proliferating capillaries 
surrounded by few lymphocytes, adipose tissue and skeletal 
muscle with areas of hyalinization and atrophy. There was 
no evidence of malignancy. Bone marrow aspirate showed 
hypocellular marrow particles suggestive of aplastic anae-
mia. Trephine biopsy showed bony trabeculae with a mar-
kedly hypocellular marrow space in which normal marrow 
elements including megakaryocytes were not observed.
table 1. Sequelae of events in the development of disease.
table 2. Oral findings in Dyskeratosis congetina.
AGE SIGNS & SYMPTOMS TREATMENT 
5 years Nail atrophy of digits, hypopigmented areas of 
skin over face  
No treatment 
6 years Hyper & hypopigmented areas all over the body  Vitamin supplements, 
topical cream 
8 years Nail atrophy of toes, diffuse skin pigmentation  No treatment  
14 years Finger nails split & lost No treatment  
20 years Redness & watering of left eye, photophobia  Eye drops 
22 years White patch on tongue -
Complications Manifestations Etiology 
Infections Dental caries, Periodontitis and 
oral ulcerations 
Defects in enamel , ectoderamal 
structures and neutropenia 
Hematologic Bleeding and atrophic glossitis Thombocytopenia and anaemia due 
to bone marrow supression 
Oral mucosa Leukoplakia, lichenoid lesions, 
pigmentation 
Genetic, GVHD* and post 
inflammatory pigmentation 
Tooth Related 
a)In longitudinal ground sections7
b) Clinical observations 
Thin enamel, indistinct 
incremental lines of Retzius, 
scanty enamel spindles, short 
enamel tufts, absence of gnarled 
enamel, abundance of enamel 
lamellae & flat interface between 
enamel & dentine 
Hypodontia, delayed eruption & 
short blunted roots 
Defects in the ectodermal and 
ectomesenchymal derivatives 
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DIscUssION
DC is a fatal condition with multisystem manifestations. 
There are X-linked, autosomal dominant and autosomal 
recessive forms of DC(3,4). It mainly occurs in the males, 
inherited as X linked recessive disorder with male:fema-
le predilection of  13:1(3). Occurrence in extremely low 
percentage of the females suggests that there are subsets 
inherited in an autosomal dominant fashion(3). Autosomal 
dominant form of dyskeratosis congenita is associated with 
mutations in the RNA component of telomerase, hTERC, 
while X linked dyskeratosis congenita is due to mutations 
in the gene encoding dyskerin, a protein implicated in both 
telomerase function and RNA processing(5).  In DC mul-
tiple organ systems are affected due to pleiotropic mutation 
in the gene(6).
In DC both the hard and the soft tissues in the oral cavity 
are affected. Oral mucosal changes manifests in the form 
of a white keratotic patch. Earlier cases reported of vesicles 
and ulcerations preceding development of leukoplakia(7). 
But these may represent herpetic infections which may 
occur due to immunocompromised status of these patients 
secondary to bone marrow suppression(8). In our case the 
patient had no vesicles or ulcerations or any other associated 
oro-mucosal abnormality.
Intraorally, the white patch may affect the buccal mucosa, 
tongue or palate, with tongue most commonly affected(1) 
as seen in our patient. Usually, white patch associated with 
dyskeratosis congenita is leukoplakia but lichen planus or 
lichenoid lesions instead of leukoplakia are also reported(5). 
Lichenoid lesions may be a component of chronic graft 
versus host disease. Electron microscopy studies revealed 
that cells in dyskeratosis congenita have an embryonic 
immature nucleus, which have higher chances to undergo 
malignant transformation(9). In addition, barrier zone of 
epithelium is less effective in dyskeratosis congenita than the 
normal epithelium causing increased permeability of noxio-
us substances and carcinogens to the germinal layers(10). 
Hence increased malignant transformation rate is seen in 
leukoplakic areas associated with dyskeratosis congenita(9). 
However, in the case reported here the biopsy report was 
not suggestive of any malignant changes. 
In DC severe periodontal destruction occur due to anoma-
lies in ectodermally derived structures and diminished host 
response caused by neutropenia(10). Patients have gingival 
inflammation, bleeding, recession and bone loss that simu-
lates juvenile periodontitis(10). In addition there may be de-
fects in the structure of the enamel like hypocalcification(7) 
that may cause dental caries. However, our patient had a 
healthy periodontium and teeth were normal.
Dermatologic manifestations occur in form of  reticular 
hyperpigmentation of skin. These pigmented areas are asso-
ciated with atrophy of epidermis, capillary hyperplasia and 
melanin pigment deposited near the blood vessels(3,6). Such 
pigmentation was observed in our patient over the skin of 
the face (Fig-1) and chest. Dystrophy of nails is associated 
with the onset of skin pigmentation(2). Nail abnormalities 
can result in longitudinal splitting and furrowing. Nails are 
Fig. 1. Extraoral photograph showing pigmented lesions and 
reddening of the left eye.
Fig. 2. Photograph showing cracking and 
missing nails of the toe.
Fig. 3. Photograph showing cracking and missing nails of 
the hand.
Fig. 4. Intra oral photograph showing a white patch on the 
dorsum of the tongue.
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brittle or completely lost(3). In our patient skin and nail 
changes started simultaneously (Table-2) and nails were 
atrophied with absence of nails in some digits (Fig-2).
In DC eye involvement can lead to epiphora, growth in 
fundus, blepharitis and loss of eyelashes(3). Our patient had 
a growth in the left fundus of the eye but biopsy could not 
be performed to ascertain the nature of the lesion.
Majority of  patients develop a haematopoietic disorder 
resembling Fanconi’s anaemia because initially the bone 
marrow is normal but gradually fat cells and fibrotic tissue 
replace the haematopoietic cells(7). Haematopoietic disorder 
manifests as marrow hypoplasia, anaemia or thrombocyto-
penia(6). With development of pancytopenia there occurs 
secondary infections that is the cause of death in majority 
of these patients(6,10). In addition to marrow failure and 
malignant changes in white patches, pulmonary complica-
tions are also serious complications in patients with DC(11). 
Our patient was pale and had anemia. Moreover, marrow 
was hypocellular and patient had thrombocytopenia.
Immunologic abnormalities occur affecting both the humo-
ral and cell mediated immunity causing high incidence of 
opportunistic infections(6,10). Abnormalities in cell media-
ted immunity is evident by delayed hypersensitivity reaction 
to skin test (antigen inoculation) and no sensitization to 
dinitrochlorobenzene(6). Abnormalities in immune syste-
ms like lymphoid depletion, absence of primary germinal 
follicles and fibrosis of lymph nodes can also occur(6). No 
opportunistic infections were seen in this patient. Tests to 
confirm these immunological abnormalities were also not 
performed.
There may be hyperpigmentation of  the buccal mucosa 
that may be reactive post inflammatory hypermelanosis(8). 
Other abnormalities like alopecia, taurodontism, mental re-
tardation, small genitals premature aging, nutmeg liver, hor-
seshoe kidneys, amyloidosis and development of Hodgkin’s 
disease and adenocarcinoma are also reported(3,6,8) but 
not observed in this patient.
DIFFERENtIAl DIAgNOsIs
The differential diagnosis includes fanconi’s anaemia, pach-
yonychia congenital, white spongy nevus and Graft versus 
host disease (GVHD). 
DC is considered as a variant of Fanconi’s anaemia because 
aplastic anaemia and cutaneous pigmentation occur in both 
but the two conditions differ from each other. Fanconi’s 
anaemia may have a possible association with oral squamous 
cell carcinoma(12). In contrast to Dyskeratosis congenita, 
Fanconi’s anaemia is an autosomal dominant condition 
with concomitant skeletal and renal abnormalities. But there 
is no nail dystrophy or oral leukoplakia seen in Fanconi’s 
anaemia as reported in this case. 
Pachyonychia congenita is an autosomal dominant con-
dition characterized by nail abnormalities, hyperkeratosis 
or hyperhidrosis of the palms and the sole and mucosal 
leukoplakia. In Pachyonychia congenita the nails become 
thick and shed at an early age and the mucosal leukoplakias 
do not undergo malignant transformation. Hematological 
abnormalities do not occur in pachyonychia congenita. 
White spongy nevus is a congenital leukokeratosis that 
presents with diffuse milky-white plaques on oral mucous 
membrane. The keratotic plaques are extensive and persist 
through out life, without a tendency for malignant transfor-
mation. It is not associated with skin, nail or hematological 
abnormalities as seen in DC.
In patients with DC who have undergone bone marrow 
transplantation, graft versus host disease can be conside-
red as a differential diagnosis(8) because they have several 
features in common(13), including skin and nail changes. 
DC should be suspected in cases where the chronological 
pattern is not consistent with chronic graft versus host disea-
se. In DC leukoplakias rather than lichenoid lesions occur. 
If  white lesion shows lichenoid lesion like characteristics 
GVHD should be suspected. 
tREAtmENt 
There is no effective and curative treatment for DC. Some 
interceptive and preventive measures can be adopted for 
which an early diagnosis is essential. Patient should be kept 
under observation and recalled for periodic follow up (14). 
In follow-up visits biopsy and complete blood picture should 
be advised to detect any malignant changes in white patches 
or developing haematopoietic disorder.
Chemotherapy with bleomycin or cyclophosphamide is 
effective for treating leukoplakia(1) associated with DC. 
Tomita and Ishii(15) reported that a vitamin A derivative, 
etretinate is effective for treating leukoplakia in DC. Howe-
ver side effects like exfoliative cheilitis, angular cheilitis 
and teratogenicity can occur. Excisional biopsy can also 
be indicated to eliminate the possibility of  development 
of carcinoma in leukoplakic areas. For extensive lesions 
in which surgery is not possible administration of steroids 
and testosterone can be used(1,4). In future gene therapy 
can provide an alternative therapy for management of this 
fatal condition.
cONclUsION
In a young patient, if  a white keratotic patch is observed 
without history of tobacco consumption with concomitant 
muco-cutaneous and systemic disorders a clinician should 
suspect Dyskeratosis Congenita.  Dentist should be able to 
recognize this fatal condition in its early stages and advice 
appropriate hematological investigations. Biopsy of  the 
white patch should be performed and patient recalled for 
regular follow up. Dentists may be first to see and diagnose 
Dyskeratosis Congenita and have an important role in mo-
nitoring the oral malignant changes in the mucosa.
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